Partial Splenic Embolization for the Treatment of Hypersplenism in Liver Transplanted Patients with Hepatitis C Virus Recurrence before peg-Interferon Plus Ribavirin
- 15 June 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 79 (11), 1634-1635
- https://doi.org/10.1097/01.tp.0000155424.52939.3d
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon ??2b and ribavirin: an open-label series1Transplantation, 2004
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- IMPACT OF THE RECURRENCE OF HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION ON THE LONG-TERM VIABILITY OF THE GRAFT1Transplantation, 2002
- HCV-related fibrosis progression following liver transplantation: increase in recent yearsJournal of Hepatology, 2000
- An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejectionHepatology, 1995
- Partial splenic embolization for the treatment of hypersplenism in cirrhosisHepatology, 1993